SCHEMBL7985164

SCHEMBL7985164

Cc1ccc(Cn2cnc3nc(-c4ccc(F)cc4)[nH]c(=O)c32)cc1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
HPGD P15428 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 3/20 0.43
MET P08581 2/20 0.41
TYMS P04818 1/20 0.41
TNKS O95271 3/20 0.40
TNKS2 Q9H2K2 3/20 0.40
PARP2 Q9UGN5 2/20 0.40
MAPT P10636 2/20 0.38
RET P07949 1/20 0.38
KDR P35968 1/20 0.38
PARP1 P09874 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984279 0.94 SMN1; SMN2 (0.47) KMT2AHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL7985058 0.90 HPGD (0.44) KMT2AHPGDALDH1A1SMN1; SMN2TNKS
SCHEMBL7974505 0.89 SMN1; SMN2 (0.55) KMT2AMEN1HPGDALDH1A1SMN1; SMN2
SCHEMBL7986518 0.89 SMN1; SMN2 (0.53) KMT2AMEN1HPGDALDH1A1SMN1; SMN2
SCHEMBL7984716 0.89 SMN1; SMN2 (0.53) KMT2AMEN1HPGDALDH1A1SMN1; SMN2
SCHEMBL7987359 0.88 TNKS (0.48) KMT2AHPGDALDH1A1SMN1; SMN2MET
SCHEMBL7985270 0.88 ALDH1A1 (0.44) KMT2AHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL7985823 0.88 HPGD (0.44) KMT2AHPGDALDH1A1SMN1; SMN2KDM4E
SCHEMBL7974466 0.87 HPGD (0.43) KMT2AMEN1HPGDALDH1A1SMN1; SMN2
SCHEMBL7988564 0.87 HPGD (0.47) KMT2AMEN1HPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed